Silence Therapeutics (SLN) Q4 2025 Earnings

5MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q4 2025
-0.43
-0.3
-0.17
-0.04

Details

Expected EPS
-0.43
Actual EPS
-0.27
Surprise EPS
0.16
Surprise Percent
+37.21%

Description

Silence Therapeutics (SLN) has reported earnings of -0.27 per share for Q4 2025.

0 Comments

Share your thoughts